TAKTakeda Pharmaceutical Co. Ltd

$17.30
$-0.33 (-2%)

Takeda Pharmaceutical Co. Ltd (TAK) Stock Analysis

Create a FREE Account to View Full TAK Stock Report

Takeda Pharmaceutical Co. Ltd (TAK) Analyst Forecast

Next 12 months ➝Current Price$17.3052-week High$21.6152-week Low$16.10MEAN$23.87+37.95%HIGH$28.00+61.85%LOW$19.50+12.72%
  • Last Price$17.30
  • Previous Close$17.63
  • Change $-0.33
  • Open$17.15
  • Volume1,902,736
  • Avg. Volume (100-day)1,254,662
  • Market Capitalization$53.89B
  • Days Range $16.92 - $17.31
  • 52-week Range $16.10 - $21.61
  • Dividend Yield4.66%
  • Ex. Dividend Date09/27/2019
  • P-E
  • EPS0.7
  • Earnings Date05/12/2020
  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • Avg. Analyst Rec.
  • Beta0.634
  • PEG Ratio
  • Volatility0.26
  • Average True Range0.01
Takeda Pharmaceutical Co Ltd ("Takeda") is Japan's largest pharmaceutical company, with revenue of JPY 2.1 trillion in 2018. In January 2019, it closed its acquisition of Shire Plc ("Shire"), a diversified, Ireland-based specialty drug firm with $15 billion revenue in 2017, mostly derived from the U.S.. In future, management intends to focus future R&D and sales efforts on five areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which comprise approximately 75% of revenue.